Study protocol: Insulin and its role in cancer

BMC Endocrine Disorders

Volumn 7, Issue , 2007, Pages

  Harish, K ^a   Dharmalingam, Mala ^a   Himanshu, M ^a  

^a M S RAMAIAH MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; SOMATOMEDIN C;

ADULT; ANALYTICAL ERROR; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DATA COLLECTION METHOD; EPITHELIUM TUMOR; FEMALE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; PROTEIN BLOOD LEVEL; SAMPLE SIZE; SOLID TUMOR; STATISTICAL ANALYSIS;

EID: 37549025732     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-7-10     Document Type: Article

References (27)

1. Wolf I Sadetzki S Catane R Karasik A Kaufman B Diabetes mellitus and breast cancer Lancet Oncol 2005, 6(2):103-111. 10.1016/ S1470-2045(05)01736-5 15683819
2. Czyzyk A Szczepanik Z Diabetes mellitus and cancer Eur J Intern Med 2000, 11(5):245-252 10.1016/S0953-6205(00)00106-0 11025248
3. Renehan AG Shalet SM Diabetes, insulin therapy, and colorectal cancer Bmj 2005, 330(7491):551-552. 554015 15760973 10.1136/bmj.330.7491.551
4. Giovannucci E Pollak MN Platz EA Willett WC Stampfer MJ Majeed N Colditz GA Speizer FE Hankinson SE A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women Cancer Epidemiol Biomarkers Prev 2000, 9(4):345-349. 10794477
5. Anderson KE Anderson E Mink PJ Hong CP Kushi LH Sellers TA Lazovich D Folsom AR Diabetes and endometrial cancer in the Iowa women's health study Cancer Epidemiol Biomarkers Prev 2001, 10(6):611-616. 11401910
6. Wolf I Sadetzki S Gluck I Oberman B Ben-David M Papa MZ Catane R Kaufman B Association between diabetes mellitus and adverse characteristics of breast cancer at presentation Eur J Cancer 2006, 42(8):1077-1082. 10.1016/j.ejca.2006.01.027 16574404
7. Pollak M Insulin-like growth factor physiology and cancer risk Eur J Cancer 2000, 36(1): 1224-1228. 10.1016/S0959-8049(00)00102-7 10882860
8. Lillioja S Mott DM Spraul M Ferraro R Foley JE Ravussin E Knowler WC Bennett PH Bogardus C Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians N Engl J Med 1993, 329(27):1988-1992. 10.1056/NEJM199312303292703 8247074
9. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) Jama 2001, 285(19):2486-2497. 10.1001/jama.285.19.2486 11368702
10. Pollak M Insulin-like growth factor physiology and neoplasia Growth Horm IGF Res 2000, 10(Suppl A): S6-7. 10.1016/S1096-6374(00)90002-9 10984271
11. Conover CA Lee PD Kanaley JA Clarkson JT Jensen MD Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans J Clin Endocrinol Metab 1992, 74 (6):1355-1360. 10.1210/ jc.74.6.1355 1375600
12. Cohen P Peehl DM Lamson G Rosenfeld RG Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells J Clin Endocrinol Metab 1991, 73(2):401-407. 1713219
13. Larsson O Girnita A Girnita L Role of insulin-like growth factor 1 receptor signalling in cancer Br J Cancer 2005, 92(12):2097-2101. 10.1038/sj.bjc.6602627 15956962
14. Wifredo Ricart J-M Fernández-Real No Decrease in Free IGF-I with Increasing Insulin in Obesity-Related Insulin Resistance Obesity Research 2001, 9: 631-636. 11595780
15. Camacho-Hubner C Insulin-like growth factor-binding proteins and neoplasia: An overview Growth Horm IGF Res 2000, 10(Suppl A):S14-15. 10.1016/S1096-6374(00)90006-6 10984275
16. Holly JM Gunnell DJ Davey Smith G Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer? J Endocrinol 1999, 162(3):321-330. 10.1677/joe.0.1620321 10467223
17. Giudice LC IGF binding protein-3 protease regulation: How sweet it is! J Clin Endocrinol Metab 1995, 80(8):2279-2281. 10.1210/jc.80.8.2279 7543109
18. Clemmons DR The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity J Clin Invest 2004, 113(1):25-27. 300772 14702105 10.1172/JCI200420660
19. Janssen JA Stolk RP Pols HA Grobbee DE de Jong FH Lamberts SW Serum free IGF-I, total IGF-I, IGFBP-1 and IGFBP-3 levels in an elderly population: relation to age and sex steroid levels Clin Endocrinol (Oxf) 1998, 48(4):471-478. 10.1046/j.1365-2265.1998.00300.x 9640414
20. Cruickshank JK Heald AH Anderson S Cade JE Sampayo J Riste LK Greenhalgh A Taylor W Fraser W White A Gibson JM Epidemiology of the insulin-like growth factor system in three ethnic groups Am J Epidemiol 2001, 154(6):504-513. 10.1093/aje/154.6.504 11549555
21. American Diabetes Association Diagnosis and classification of diabetes mellitus (Position Statement) Diabetes Care 2007, 30(Suppl 1):S42-47. 10.2337/dc07-S042 17192378
22. Shirodkar M Mohandas KM Subjective global assessment: A simple and reliable screening tool for malnutrition among Indians Indian J Gastroenterol 2005, 24(6):246-250. 16424621
23. Jayagopal V Kilpatrick ES Jennings PE Hepburn DA Atkin SL Biological variation of homeostasis model assessment-derived insulin resistance in type 2 diabetes Diabetes Care 2002, 25(11):2022-2025. 10.2337/ diacare.25.11.2022 12401750
24. Pollak M The question of a link between insulin-like growth factor physiology and neoplasia Growth Horm IGF Res 2000, 10(Suppl B):S21-24. 10.1016/S1096-6374(00)80005-2 10984249
25. Smith GD Gunnell D Holly J Cancer and insulin-like growth factor-I. A potential mechanism linking the environment with cancer risk Bmj 2000, 321(7265):847-848. 1118665 11021847 10.1136/bmj.321.7265.847
26. North KE Williams K Williams JT Best LG Lee ET Fabsitz RR Howard BV Gray RS MacCluer JW Evidence for genetic factors underlying the insulin resistance syndrome in american indians Obes Res 2003, 11(12):1444-1448. 14694207
27. Polonsky KS Sturis J Bell GI Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance N Engl J Med 1996, 334(12):777-783. 10.1056/ NEJM199603213341207 8592553